P-Monofer-CKD-04: A Phase III, Randomised, Open-Label, Comparative Safety and Efficacy Trial of Intravenous Iron Isomaltoside (Monofer) and Iron Sucrose in Subjects with Iron Deficiency Anemia and Non-Dialysis-Dependent Chronic Kidney Disease